Literature DB >> 33471879

Herpes zoster may be a marker for COVID-19 infection during pregnancy.

Mohamed L Elsaie1, Eman A Youssef2, Hesham A Nada3.   

Abstract

Varicella-zoster virus infection causes 2 distinct forms of disease: varicella (commonly known as chickenpox) and herpes zoster (HZ)(commonly known as shingles). Primary varicella-zoster virus infection results in the diffuse vesicular rash that is characteristic of chickenpox. Following primary infection, varicella-zoster virus remains dormant in the dorsal root ganglia. This latent phase usually lasts for several decades before reactivation occurs. Varicella-zoster virus reactivation normally presents as HZ in middle-aged adults. A number of cutaneous skin manifestations have appeared in relation to the newly diagnosed coronavirus disease 2019 (COVID-19) pandemic and continue to emerge every day. We report a case of HZ complication in a COVID-19-positive woman who was 27 weeks pregnant.

Entities:  

Year:  2020        PMID: 33471879     DOI: 10.12788/cutis.0133

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  7 in total

Review 1.  Dermatology in a multidisciplinary approach with infectious disease and obstetric medicine against COVID-19.

Authors:  Rachel K Lim; Saisanjana Kalagara; Kenneth K Chen; Eleftherios Mylonakis; George Kroumpouzos
Journal:  Int J Womens Dermatol       Date:  2021-08-26

Review 2.  Herpes zoster and COVID-19 infection: a coincidence or a causal relationship?

Authors:  Salim Ali Algaadi
Journal:  Infection       Date:  2021-11-22       Impact factor: 7.455

3.  Herpes zoster in the era of COVID 19: A prospective observational study to probe the association of herpes zoster with COVID 19 infection and vaccination.

Authors:  Nawaf Almutairi; Abdulrahman N Almutairi; Moneerah Almazyad; Sabika Alwazzan
Journal:  Dermatol Ther       Date:  2022-04-29       Impact factor: 3.858

Review 4.  Characteristics of herpes zoster infection in patients with COVID-19: a systematic scoping review.

Authors:  Torrey Czech; Yoshito Nishimura
Journal:  Int J Dermatol       Date:  2022-05-03       Impact factor: 3.204

5.  Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: New insights.

Authors:  Raquel Martinez-Reviejo; Sofia Tejada; Ganiyat A R Adebanjo; Camilla Chello; Miriam C Machado; Francesca R Parisella; Magda Campins; Antonella Tammaro; Jordi Rello
Journal:  Eur J Intern Med       Date:  2022-08-01       Impact factor: 7.749

6.  Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2.

Authors:  Mina Psichogiou; Michael Samarkos; Nikolaos Mikos; Angelos Hatzakis
Journal:  Vaccines (Basel)       Date:  2021-06-01

7.  Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2.

Authors:  Marlene Plüß; Kemal Mese; Johannes T Kowallick; Andreas Schuster; Désirée Tampe; Björn Tampe
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.